NCT01203826View on ClinicalTrials.gov

Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Hypophosphatasia (HPP)
Interventions
BIOLOGICAL

Asfotase Alfa

Trial Locations (2)

63110

Shriners Hospital for Children, St Louis

R3A 1S1

Children's Hospital Health Sciences Centre, Winnipeg

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY